We initially are developing our lead product candidate, MST-188, as a treatment for complications arising from sickle cell disease.
If you are a sickle cell disease patient or would like to learn more about the disease and/or how you can help, please take a moment to view our Patient Resources links below.
Click above to find your local SCD support organizations.
Click above to view an updating global SCD news feed.
Click above to view additional SCD links.
Click here to view our latest press releases, SEC filings, and information about company events, media, and analyst coverage. read more
Click here to learn more about our lead product candidate, MST-188, as well as our other technologies. read more